AbouEzzeddine, Omar F <br/><br/>
Galectin-3 in heart failure with preserved ejection fraction. A RELAX trial substudy (Phosphodiesterase-5 Inhibition to Improve Clinical Status and Exercise Capacity in Diastolic Heart Failure).  [electronic resource] 

 -  JACC. Heart failure  Mar 2015 
 - 245-52 p.  digital 
<br/><br/> Publication Type: Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, N.I.H., Extramural 
<br/><br/><label>ISSN: </label>2213-1787 
<br/><br/><label>Standard No.: </label>10.1016/j.jchf.2014.10.009  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Aged<br/>Enzyme-Linked Immunosorbent Assay<br/>Exercise Tolerance--drug effects<br/>Female<br/>Galectin 3--blood<br/>Heart Failure, Diastolic--blood<br/>Humans<br/>Male<br/>Middle Aged<br/>Phosphodiesterase 5 Inhibitors--therapeutic use<br/>Quality of Life<br/>Stroke Volume--drug effects<br/>Ventricular Function, Left--drug effects